<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7298161\results\search\country\results.xml">
  <result pre="Review Article Overview of therapeutic drug research for COVID-19 in" exact="China" post="LiHeng12YangLi1LiuFei-fei12MaXin-na3HePei-lan1TangWei1TongXian-kunxktong@simm.ac.cn1ZuoJian-pingjpzuo@simm.ac.cn123[1], 0000000119573309grid.9227.eLaboratory of Immunopharmacology, Shanghai Institute of MateriaMedica, Chinese"/>
  <result pre="SARS-CoV-2 as of April 22. In response to this epidemic," exact="China" post="has issued seven trial versions of diagnosis and treatment"/>
  <result pre="a new type of unexplained pneumoniaÂ appeared in the South" exact="China" post="Seafood Wholesale Market in Wuhan, Hubei Province, but its"/>
  <result pre="and MERS-CoV [1]. After the alert of this new pathogen," exact="China" post="quickly took measures to completely block off Hubei Province"/>
  <result pre="in Fig. 2. Overview of COVID-19 drug-related clinical trials in" exact="China" post="Due to the sudden emergence of SARS-CoV-2, no specific"/>
  <result pre="such a short period of time, we can see that" exact="China" post="has responded to the epidemic in a timely manner"/>
  <result pre="twice a day [13]. Lopinavir/ritonavir Lopinavir was first approved in" exact="the United States" post="in 2000 for the treatment of HIV infection [20]."/>
  <result pre="a day [13]. Lopinavir/ritonavir Lopinavir was first approved in the" exact="United States" post="in 2000 for the treatment of HIV infection [20]."/>
  <result pre="A and B viruses, and it was first approved in" exact="Russia" post="[43]. It can inhibit the adhesion of viruses to"/>
  <result pre="inhibit RNA-dependent polymerase [52] and was approved for marketing in" exact="Japan" post="in 2014. It is used for antiviral treatment of"/>
  <result pre="EC50 of 0.77â€‰Î¼M [39]. Recently, the first COVID-19 patient in" exact="the United States" post="was treated with remdesivir on the 7th day of"/>
  <result pre="of 0.77â€‰Î¼M [39]. Recently, the first COVID-19 patient in the" exact="United States" post="was treated with remdesivir on the 7th day of"/>
  <result pre="Reports announced that up to 90% of COVID-19 patients in" exact="China" post="have been given Chinese patent medicine or TCM prescriptions."/>
  <result pre="modeling of its spike protein for risk of human transmissionSci" exact="China" post="Life Sci2020634576032009228 2.ZhangNWangLDengXLiangRSuMHeCet al.Recent advances in the detection of"/>
 </snippets>
</snippetsTree>
